Literature DB >> 2539815

Correlation between the antiviral activity of acyclic and carbocyclic adenosine analogues in murine L929 cells and their inhibitory effect on L929 cells S-adenosylhomocysteine hydrolase.

M Cools1, E de Clercq.   

Abstract

For a series of acyclic and carbocyclic adenosine analogues, a close correlation was found between their inhibitory effect on murine L929 cell S-adenosylhomocysteine (AdoHcy) hydrolase and their inhibitory effects on the replication of vaccinia virus and vesicular stomatitis virus (r: 0.993 and 0.988, respectively). In terms of their increasing inhibitory action against both virus replication and AdoHcy hydrolase activity the compounds ranked as follows: (S)-9-(2,3-dihydroxypropyl)adenine less than (RS)-3-adenin-9-yl-2-hydroxypropanoic acid (isobutyl ester) less than 3-deazaneplanocin A approximately carbocyclic 3-deazaadenosine less than adenosine dialdehyde less than neplanocin A. These findings point to AdoHcy hydrolase as the target for the antiviral action of these adenosine analogues.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2539815     DOI: 10.1016/0006-2952(89)90249-9

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  10 in total

1.  Broad-spectrum antiviral activities of neplanocin A, 3-deazaneplanocin A, and their 5'-nor derivatives.

Authors:  E De Clercq; M Cools; J Balzarini; V E Marquez; D R Borcherding; R T Borchardt; J C Drach; S Kitaoka; T Konno
Journal:  Antimicrob Agents Chemother       Date:  1989-08       Impact factor: 5.191

2.  Antiviral activities of 5-ethynyl-1-beta-D-ribofuranosylimidazole-4- carboxamide and related compounds.

Authors:  E De Clercq; M Cools; J Balzarini; R Snoeck; G Andrei; M Hosoya; S Shigeta; T Ueda; N Minakawa; A Matsuda
Journal:  Antimicrob Agents Chemother       Date:  1991-04       Impact factor: 5.191

Review 3.  Vaccinia virus inhibitors as a paradigm for the chemotherapy of poxvirus infections.

Authors:  E De Clercq
Journal:  Clin Microbiol Rev       Date:  2001-04       Impact factor: 26.132

4.  Pharmacokinetics of the antiviral agent 3-deazaneplanocin A.

Authors:  R A Coulombe; R P Sharma; J W Huggins
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1995 Jul-Sep       Impact factor: 2.441

5.  Substrate-dependent dihydroxylation of substituted cyclopentenes: toward the syntheses of carbocyclic sinefungin and noraristeromycin.

Authors:  May Xiao-Wu Jiang; Bohan Jin; Jennifer L Gage; Alain Priour; Gordon Savela; Marvin J Miller
Journal:  J Org Chem       Date:  2006-05-26       Impact factor: 4.354

6.  Diastereoselective synthesis of a spironoraristeromycin using an acylnitroso Diels-Alder reaction.

Authors:  Weimin Lin; Kristopher G Virga; Kyung-Hee Kim; Jaroslav Zajicek; David Mendel; Marvin J Miller
Journal:  J Org Chem       Date:  2009-08-21       Impact factor: 4.354

7.  Carbocyclic 4'-Epiformycin.

Authors:  Jian Zhou; Minmin Yang; Akin Akdag; Haisheng Wang; Stewart W Schneller
Journal:  Tetrahedron       Date:  2008-01-07       Impact factor: 2.457

8.  Broad-spectrum antiviral activity of carbodine, the carbocyclic analogue of cytidine.

Authors:  E De Clercq; R Bernaerts; Y F Shealy; J A Montgomery
Journal:  Biochem Pharmacol       Date:  1990-01-15       Impact factor: 5.858

9.  6'-β-Fluoro-Homoaristeromycin and 6'-Fluoro-Homoneplanocin A Are Potent Inhibitors of Chikungunya Virus Replication through Their Direct Effect on Viral Nonstructural Protein 1.

Authors:  Kristina Kovacikova; Bas M Morren; Ali Tas; Irina C Albulescu; Robin van Rijswijk; Dnyandev B Jarhad; Young Sup Shin; Min Hwan Jang; Gyudong Kim; Hyuk Woo Lee; Lak Shin Jeong; Eric J Snijder; Martijn J van Hemert
Journal:  Antimicrob Agents Chemother       Date:  2020-03-24       Impact factor: 5.191

Review 10.  Advances in Therapeutic L-Nucleosides and L-Nucleic Acids with Unusual Handedness.

Authors:  Yuliya Dantsu; Ying Zhang; Wen Zhang
Journal:  Genes (Basel)       Date:  2021-12-24       Impact factor: 4.096

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.